Following the resolution of Eli Lilly’s tirzepatide shortage in October, the FDA has officially declared an end to the supply ...

But 25-year-old Madison Burgess has thrown caution to the wind by opting to micro-dose the drug. The Michigan native revealed ...

A randomized, placebo-controlled trial validates a side effect frequently observed by doctors and patients. A new study from ...

The Food and Drug Administration on Friday announced that semaglutide, the active ingredient in weight loss drugs Ozempic and ...

"They’re priced for profits, not patients.” That’s the critique from Hims & Hers Health’s buzzy — and controversial — Super ...

Semaglutide could help people drink less alcohol. Semaglutide, a medication widely used for diabetes and weight loss, may offer another unexpected benefit -- it could help people drink less alcohol.

Semaglutide is an injectable medication typically used to treat diabetes. However, it can also be prescribed for weight loss under the brand name Wegovy. Semaglutide is a prescription medication ...

Weight-loss injections slash alcohol ... more research Researchers said the study backs up anecdotal evidence from patients and doctors that semaglutide can lead to a sudden loss of longing ...

It also suppresses appetite and boosts feelings of fullness, which can then lead to reduced food intake and potential weight loss. Ozempic, Wegovy, and compounded semaglutide are once-weekly ...

Ozempic is synonymous with weight loss for many people. Doctors explain benefits and risks of semaglutide and other GLP-1 ...

When you buy through links on our articles, Future and its syndication partners may earn a commission.

That’s the critique from Hims & Hers Health’s buzzy — and controversial — Super Bowl ad, leveling the accusation against brand-name weight loss ... taking compounded semaglutide. How many is unclear.